<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52725">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02419794</url>
  </required_header>
  <id_info>
    <org_study_id>UMIN000015273</org_study_id>
    <nct_id>NCT02419794</nct_id>
  </id_info>
  <brief_title>Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2</brief_title>
  <official_title>Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hyogo College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hyogo College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to clarify treatment status and clinical results of acute cerebral
      ischemia after approval of clot retriever in Japan, and also to obtain a basis for
      comparative studies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>90 Days</target_duration>
  <primary_outcome>
    <measure>modified Rankin Scale (mRS) at 90 days (+/- 10 days) after onset</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death within 90 days (+/- 10 day) after the onset</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of mRS score 0-2 at each affected artery</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic intracranial hemorrhage within 72 hours (+/- 8 hours) after onset</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference of NIHSS score between pre-treatment and at 72 hours (+/- 8 hours) after onset</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">19</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Group with endovascular treatment</arm_group_label>
    <description>Group with additional endovascular treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group without endovascular treatment</arm_group_label>
    <description>Group without additional endovascular treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endovascular treatment</intervention_name>
    <description>endovascular treatment for acute ischemic stroke patients with large vessel occlusion</description>
    <arm_group_label>Group with endovascular treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Acute cerebral large vessel occlusion admitted within 24 hours after onset.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted from Oct. 1st 2014 to Sep. 30st 2016.

          -  Patients who were 20 years and older admitted within 24 hours after onset.

          -  The patients with large vessel occlusion (ICA, MCA, VA, BA, PCA).

          -  Patients who did not fulfill the criteria of RESCUE-Japan RCT.

        Exclusion Criteria:

        ï½¥Patients who are considered inappropriate to participate in the study are excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shinichi Yoshimura, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hyogo College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hyogo College of Medicine</name>
      <address>
        <city>Nishinomiya</city>
        <state>Hyogo</state>
        <zip>663-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 2, 2017</lastchanged_date>
  <firstreceived_date>January 19, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hyogo College of Medicine</investigator_affiliation>
    <investigator_full_name>Shinichi Yoshimura</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
